vancomycin has been researched along with Infectious Skin Diseases in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (17.86) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 10 (35.71) | 29.6817 |
| 2010's | 9 (32.14) | 24.3611 |
| 2020's | 3 (10.71) | 2.80 |
| Authors | Studies |
|---|---|
| Abbanat, D; Bush, K; Fernandez, J; Flamm, RK; Hilliard, JJ; Melton, JL; Santoro, CM; Zhang, W | 1 |
| Burgoon, R; Mediwala, KN; Raux, BR; Weeda, E | 1 |
| Lynch, JP; Zhanel, GG | 1 |
| Li, H; Li, Z; Lyu, C; Shen, J; Wang, X; Zhang, L | 1 |
| Candela Fajardo, A; Gallego Muñoz, C; Urbieta Sanz, E | 1 |
| Azzini, AM; Baur, D; Savoldi, A; Tacconelli, E | 1 |
| Huang, D; Lodise, T; Patel, N | 1 |
| Adamson, RT; Amara, S; Huang, X; Lew, I | 1 |
| Barriere, SL; Corey, GR; Pushkin, R; Stryjewski, ME; Wang, W | 1 |
| Bedolla, J; Brenneman, SK; Corey, GR; Friedman, B; Garcia-Diaz, J; Hoehns, JD; Jauregui-Peredo, L; Kauf, TL; Lodise, T; McKinnon, P; Mercier, RC; Ng, D; Riska, PF; Sims, M | 1 |
| Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F | 1 |
| Barriere, SL; Friedland, HD; Hopkins, A; Kitt, MM; O'Riordan, W; Wilson, SE | 1 |
| Brandt, R; Hadvary, P; Hawser, S; Islam, K; Krievins, D | 1 |
| Bagchi, P; Kimko, H; Nandy, P; Noel, GJ; Samtani, MN; Strauss, RS; Xu, X | 1 |
| Blick, SK; Lyseng-Williamson, KA | 1 |
| Cuervo, J; Gil-Parrado, S; Grau, S; Rebollo, P | 1 |
| Arbeit, RD; Campanaro, E; Eisenstein, BI; Maki, D; Tally, FP | 1 |
| Polk, HC; Sharpe, JN; Shively, EH | 1 |
| Itani, KM; Liu, LZ; McKinnon, PS; Sorensen, SV | 1 |
| Das, A; Ge, Y; Talbot, GH; Thye, D | 1 |
| Davis, SL; Delgado, G; Hall, LM; McKinnon, PS; Rose, W; Rybak, MJ; Wilson, RF | 1 |
| Barriere, SL; Corey, GR; Fowler, VG; Friedland, HD; Graham, DR; Hopkins, A; Kitt, MM; Lentnek, A; O'Riordan, W; Ross, DP; Stryjewski, ME; Wilson, SE; Young, D | 1 |
| Peters, G; Pulverer, G | 1 |
| Counts, GW; Meyers, JD; Stamm, WE; Thomas, ED; Tompkins, LS; Wagner, KF | 1 |
| Freiman, JP; Graham, DJ; McGoodwin, EB; Reed, TG | 1 |
| Arioli, V; Berti, M; Candiani, G | 1 |
| Feingold, DS; Wagner, RF | 1 |
| Adams, RM; Remington, JS; Seibert, JS; Steinberg, J | 1 |
3 review(s) available for vancomycin and Infectious Skin Diseases
| Article | Year |
|---|---|
Is there still a role for vancomycin in skin and soft-tissue infections?
Topics: Anti-Bacterial Agents; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Glycopeptides; Humans; Linezolid; Skin Diseases, Infectious; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2018 |
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin | 2016 |
Antibacterial therapy.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Cephalosporins; Clindamycin; Drug Combinations; Erythromycin; Humans; Methicillin; Metronidazole; Nalidixic Acid; Penicillin Resistance; Penicillins; Rifampin; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
9 trial(s) available for vancomycin and Infectious Skin Diseases
| Article | Year |
|---|---|
An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection.
Topics: Adult; Anti-Bacterial Agents; Daptomycin; Drug Costs; Female; Hospital Costs; Humans; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin Diseases, Infectious; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2015 |
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections associated with surgical procedures.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Lipoglycopeptides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Skin Diseases, Infectious; Staphylococcal Infections; Surgical Wound Infection; Vancomycin | 2009 |
Multicenter, randomized study of the efficacy and safety of intravenous iclaprim in complicated skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Skin Diseases, Infectious; Staphylococcus aureus; Vancomycin; Young Adult | 2009 |
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Daptomycin; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillins; Skin Diseases, Infectious; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2004 |
Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Administration, Oral; Adult; Aged; Cost-Benefit Analysis; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Linezolid; Lower Extremity; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Probability; Reference Values; Severity of Illness Index; Single-Blind Method; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin | 2005 |
Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Clinical Trials as Topic; Cost-Benefit Analysis; Delivery of Health Care; Drug Costs; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Prospective Studies; Regression Analysis; Skin Diseases, Infectious; Streptococcal Infections; Treatment Outcome; Vancomycin | 2006 |
Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Female; Humans; Male; Methicillin Resistance; Middle Aged; Recurrence; Skin Diseases, Infectious; Streptococcus agalactiae; Treatment Outcome; Vancomycin | 2007 |
Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.
Topics: Abscess; Adult; Aged; Anti-Bacterial Agents; Cellulitis; Cost-Benefit Analysis; Daptomycin; Female; Hospital Costs; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Skin Diseases, Infectious; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2007 |
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms.
Topics: Adult; Aminoglycosides; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Male; Middle Aged; Skin Diseases, Infectious; Treatment Outcome; Vancomycin | 2008 |
16 other study(ies) available for vancomycin and Infectious Skin Diseases
| Article | Year |
|---|---|
In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Proteins; beta-Lactamases; Cephalosporins; Colony Count, Microbial; Dose-Response Relationship, Drug; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Half-Life; Immunocompromised Host; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Hairless; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus | 2010 |
Clinical utility of negative methicillin-resistant Staphylococcus aureus (MRSA) nasal surveillance swabs in skin and skin structure infections.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Respiratory Tract Infections; Retrospective Studies; Skin Diseases, Infectious; Staphylococcal Infections; Vancomycin | 2022 |
Escalation of antimicrobial resistance among MRSA part 2: focus on infections and treatment.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Infectious; Staphylococcal Infections; Vancomycin | 2023 |
Clinical efficacy of psychiatric nursing-based vancomycin in the treatment of Staphylococcus aureus infectious skin diseases.
Topics: Acetamides; Anti-Bacterial Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Psychiatric Nursing; Retrospective Studies; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2023 |
[Dalbavancin in the treatment of skin and soft tissues infection].
Topics: Anti-Bacterial Agents; Drug Eruptions; Female; Humans; Middle Aged; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Vancomycin | 2017 |
Potential for Cost Saving with Iclaprim Owing to Avoidance of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cost Savings; Folic Acid Antagonists; Hospitalization; Humans; Pyrimidines; Skin Diseases, Infectious; Vancomycin | 2018 |
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Cefazolin; Female; Hospitalization; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Skin Diseases, Bacterial; Skin Diseases, Infectious; Sulbactam; Treatment Outcome; Vancomycin | 2013 |
Telavancin for Acute Bacterial Skin and Skin Structure Infections, a Post Hoc Analysis of the Phase 3 ATLAS Trials in Light of the 2013 FDA Guidance.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Female; Humans; Lipoglycopeptides; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Skin Diseases, Infectious; Vancomycin | 2015 |
Pharmacodynamic profiling of ceftobiprole for treatment of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Skin Diseases, Infectious; Treatment Outcome; Vancomycin | 2009 |
Telavancin.
Topics: Adult; Aminoglycosides; Animals; Anti-Bacterial Agents; Cross Infection; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Skin Diseases, Infectious; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
[Pharmacoeconomic assessment of daptomycin as first-line therapy for bacteraemia and complicated skin and skin structure infections caused by gram-positive pathogens in Spain].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Daptomycin; Data Interpretation, Statistical; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Oxazolidinones; Salvage Therapy; Skin Diseases, Infectious; Spain; Treatment Failure; Vancomycin; Young Adult | 2011 |
Pathogenesis and management of Staphylococcus epidermidis 'plastic' foreign body infections.
Topics: Adhesiveness; Foreign Bodies; Humans; Infusions, Parenteral; Kinetics; Plastics; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1984 |
Infection due to Corynebacterium species in marrow transplant patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacteriological Techniques; Bone Marrow Transplantation; Child; Child, Preschool; Corynebacterium; Corynebacterium Infections; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Proctitis; Respiratory Tract Infections; Retrospective Studies; Sepsis; Sex Factors; Skin Diseases, Infectious; Vancomycin | 1979 |
Chemical peritonitis following the intraperitoneal administration of vancomycin.
Topics: Adverse Drug Reaction Reporting Systems; Catheters, Indwelling; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Skin Diseases, Infectious; United States; United States Food and Drug Administration; Vancomycin | 1992 |
Activity of teicoplanin in localized experimental infections in rats.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Glycopeptides; Granuloma; Male; Methicillin; Penicillin Resistance; Rats; Rats, Inbred F344; Rifampin; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Teicoplanin; Vancomycin | 1986 |
Tropical fish aquariums. A source of Mycobacterium marinum infections resembling sporotrichosis.
Topics: Adult; Amphotericin B; Animals; Cycloserine; Diagnosis, Differential; Ethambutol; Ethionamide; Female; Fishes; Hobbies; Humans; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Skin; Skin Diseases, Infectious; Sporotrichosis; Vancomycin | 1970 |